Home

Articles from THE SAGE GROUP

According to THE SAGE GROUP, Over 3.5 Million Critical Limb Ischemia (CLI) Patients Have Calcified Lower Limb Arteries
A new report published by THE SAGE GROUP reviews recent calcium research and quantifies the number of CLI patients with calcified leg arteries.
By THE SAGE GROUP · Via Business Wire · January 15, 2025
According to THE SAGE GROUP, The Majority of Endovascular Revascularizations Performed for Peripheral Artery Disease (PAD) are Outpatient
Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing endovascular procedures by site of service; hospital inpatient, hospital outpatient (HOPD) and office-based labs (OBLs) or ambulatory surgery centers (ASCs).
By THE SAGE GROUP · Via Business Wire · October 14, 2024
According to THE SAGE GROUP, Less Than 20% of Symptomatic Peripheral Artery Disease (PAD) Patients Are Revascularized
Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing surgical bypass and endovascular revascularization in the U.S.
By THE SAGE GROUP · Via Business Wire · September 30, 2024
According to THE SAGE GROUP, There is a Significant Need for Innovative Endovascular Devices to Treat Below-the-Ankle (BTA) Disease in Critical Limb Ischemia (CLI) Patients
Research published by THE SAGE GROUP examines the prevalence, characteristics, comorbidities and consequences of BTA disease, as well as explores the challenges of endovascular revascularization.
By THE SAGE GROUP · Via Business Wire · August 28, 2024
In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Highlights Gender Disparities in PAD
According to THE SAGE GROUP, over half of the 21 million Americans suffering from PAD are women.
By THE SAGE GROUP · Via Business Wire · September 13, 2023
According to THE SAGE GROUP, High Restenosis Rates Following Endovascular Treatment of Infrapopliteal Disease Create a Significant Need for Improved Technologies
Recent research published by THE SAGE GROUP examines the challenges of infrapopliteal Peripheral Artery Disease (PAD) and incidence of restenosis.
By THE SAGE GROUP · Via Business Wire · February 16, 2023
THE SAGE GROUP Comments on National Peripheral Artery Disease (PAD) Awareness Month
According to THE SAGE GROUP, 21 million Americans suffer from PAD representing an economic burden of $283-$539 billion.
By THE SAGE GROUP · Via Business Wire · September 13, 2022
According to THE SAGE GROUP, Gender is a Significant Factor in African American (AA) Peripheral Artery Disease (PAD) Disparities
Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA.
By THE SAGE GROUP · Via Business Wire · May 19, 2022
In Honor of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Amputation Lottery
According to, Mary L. Yost, President of THE SAGE GROUP, “The probability of undergoing major amputation (MA) depends on who you are, and where you live, ‘The Amputation Lottery.’ Amputation rates vary by race, socioeconomic status, age, sex, type of hospital and geographic location.”
By THE SAGE GROUP · Via Business Wire · September 14, 2021